Eosinophilic Esophagitis Steroid Safety Study
NCT04416217 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 55
Last updated 2025-05-07
Summary
This observational study will follow pediatric patients with eosinophilic esophagitis who are scheduled to begin topical steroid treatment, from the initiation of treatment longitudinally to determine the safety profile of the drug.
Conditions
- Eosinophilic Esophagitis
Sponsors & Collaborators
-
Rabin Medical Center
lead OTHER
Eligibility
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-10-07
- Primary Completion
- 2024-12-31
- Completion
- 2024-12-31
Countries
- Greece
- Israel
- Italy
Study Locations
More Related Trials
-
A Six Month, Safety Follow-up Study in Eosinophilic Esophagitis Subjects Who Completed Study PR-021
NCT01498497 ·Status: COMPLETED
-
Antihistamines in Eosinophilic Esophagitis
NCT04248712 ·Status: TERMINATED ·Phase: PHASE2
-
Mometasone-furoate for Treatment of Eosinophilic Esophagitis - a Randomized Placebo Controlled Study.
NCT02113267 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy and Safety APT-1011 in Adult Subjects With Eosinophilic Esophagitis (EoE) (FLUTE-2)
NCT04281108 ·Status: COMPLETED ·Phase: PHASE3
-
Montelukast in the Treatment of Duodenal Eosinophilia
NCT00148603 ·Status: COMPLETED ·Phase: NA
-
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
NCT03191864 ·Status: COMPLETED ·Phase: PHASE2
-
Compare Captisol-Enabled (CE) Budesonide + Azelastine Nasal Solution and Rhinocort Aqua + Astelin in an Environmental Exposure Chamber (EEC) Study of Allergic Rhinitis
NCT00940953 ·Status: COMPLETED ·Phase: PHASE2
-
The Efficacy and Tolerability of 12-weeks Treatment With Almond and Buckwheat Based Formula in Pediatric Patients With Active EoE
NCT05622214 ·Status: UNKNOWN ·Phase: NA
-
Steroid Treatment for Hypereosinophilic Syndrome
NCT01524536 ·Status: COMPLETED ·Phase: PHASE4
-
The Efficacy Of Elonide Nasal Corticosteroids In Managing Allergic Rhinitis
NCT05912192 ·Status: COMPLETED ·Phase: NA
-
A Study of Epinastine Nasal Spray in Subjects With Seasonal Allergic Rhinitis
NCT00407927 ·Status: COMPLETED ·Phase: PHASE2
-
As Needed Versus Regular Intranasal Corticosteroid in Children With Perennial Allergic Rhinitis
NCT05299086 ·Status: COMPLETED ·Phase: PHASE3
-
Safety Study of Anti-IgE Immunotherapy in Allergic Patients
NCT00439621 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Hypertonic Solutions on Allergic Rhinitis Patients
NCT02233426 ·Status: UNKNOWN
-
Multicenter, Double-blind, Randomized, Placebo-controlled Study of Mometasone Furoate Nasal Spray in Pediatric Subjects With Perennial Allergic Rhinitis (Study P06332)
NCT01135134 ·Status: COMPLETED ·Phase: PHASE3
-
Dose Finding for the Treatment of Rhinitis/Rhinoconjunctivitis Against Mite Allergy
NCT02661854 ·Status: UNKNOWN ·Phase: PHASE2
-
Survey About the Relationship Beetween Allergic Rhinitis and Seasonal EOE Exacerbations
NCT05755477 ·Status: UNKNOWN
-
A Study of RO4989991 in Patients With Allergic Rhinitis
NCT01152619 ·Status: COMPLETED ·Phase: PHASE1
-
A Multicenter Study to Evaluate Safety and Efficacy of Specific Immunotherapy With Modified Allergen Extracts
NCT01012752 ·Status: UNKNOWN ·Phase: PHASE3
-
Safety and Tolerability of Ciclesonide Nasal Spray in Patients With Perennial Allergic Rhinitis (2-5 Years Old) (BY9010/M1-416)
NCT00261287 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study With Allergen Extracts of House Dust Mites for Specific Sublingual Immunotherapy
NCT01014325 ·Status: UNKNOWN ·Phase: PHASE3
-
Safety and Efficacy Study of Epinastine Nasal Spray in Subjects With Seasonal Allergic Rhinitis (P08648)
NCT00564421 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Mometasone Furoate Nasal Spray With the Addition of Loratadine Versus Placebo in Participants With Seasonal Allergic Rhinitis (C94-145)
NCT03855228 ·Status: COMPLETED ·Phase: PHASE3
-
WAL801CL (Epinastine Hydrochloride) Dry Syrup in Paediatric Perennial Allergic Rhinitis
NCT02182544 ·Status: COMPLETED ·Phase: PHASE3
-
Airway Inflammation in Children With Allergic Rhinitis and Intervention
NCT02352168 ·Status: COMPLETED ·Phase: NA